A Therapy for Improving Symptoms in Patients With Acute Exacerbations of COPD by Hydrogen-Oxygen Generator With Neburlizer.

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

June 1, 2019

Study Completion Date

September 20, 2019

Conditions
Copd Exacerbation Acute
Interventions
DEVICE

oxyhydrogen

Hydrogen/oxygen mixed gas inhaled(proportion 2:1),3 L/min . 1 hour each time,twice a day(BID).Test Duration is seven days

DEVICE

Oxygen

oxygen inhaled,3 L/min . 1 hour each time,twice a day(BID).Test Duration is seven days

DRUG

Conventional treatment

Bronchodilator (LABA,LAMA) with or without ICS.Conventional treatment is invariable with which was given to COPD patients in seven days before the study

Trial Locations (1)

510000

First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

The First Hospital of Hebei Medical University

OTHER

collaborator

Fudan University

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Shanghai 10th People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Second Hospital of Shanxi Medical University

OTHER

collaborator

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

lead

Shanghai Asclepius Meditec Inc.

INDUSTRY

NCT04000451 - A Therapy for Improving Symptoms in Patients With Acute Exacerbations of COPD by Hydrogen-Oxygen Generator With Neburlizer. | Biotech Hunter | Biotech Hunter